Who invested in Callio Therapeutics?
4 investors are on record as having backed Callio Therapeutics — Antibody-drug conjugates for cancer, in Biotech, United States. Each row below says whether the round came from the investor's own portfolio page or from the press.
calliotx.comCallio Therapeutics investors
NVP Associates, LLCseries-a$187MMar 2025press
ClavystBioInvests in and builds life science companies, accelerating breakthroughs into health…their site
2 more investors on record for Callio Therapeutics.
The first two are open to everyone. A free account opens the rest — the fund, the round, the amount and where each number came from. No card, no demo call.
The funds that backed Callio Therapeutics are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.